company background image
RHT logo

Resonance Health ASX:RHT Stock Report

Last Price

AU$0.051

Market Cap

AU$24.6m

7D

-1.9%

1Y

-7.3%

Updated

23 Jul, 2024

Data

Company Financials

RHT Stock Overview

A healthcare technology and services company, designs, develops, manufactures, and commercializes software-as-medical devices in the Asia Pacific, North America, Europe, the Middle East, and Africa.

RHT fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Resonance Health Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Resonance Health
Historical stock prices
Current Share PriceAU$0.051
52 Week HighAU$0.088
52 Week LowAU$0.047
Beta1.29
11 Month Change-15.00%
3 Month Change-40.00%
1 Year Change-7.27%
33 Year Change-66.00%
5 Year Change-48.48%
Change since IPO-99.69%

Recent News & Updates

We're Interested To See How Resonance Health (ASX:RHT) Uses Its Cash Hoard To Grow

Mar 12
We're Interested To See How Resonance Health (ASX:RHT) Uses Its Cash Hoard To Grow

Recent updates

We're Interested To See How Resonance Health (ASX:RHT) Uses Its Cash Hoard To Grow

Mar 12
We're Interested To See How Resonance Health (ASX:RHT) Uses Its Cash Hoard To Grow

Resonance Health (ASX:RHT) Is In A Good Position To Deliver On Growth Plans

Aug 19
Resonance Health (ASX:RHT) Is In A Good Position To Deliver On Growth Plans

Are Robust Financials Driving The Recent Rally In Resonance Health Limited's (ASX:RHT) Stock?

Mar 01
Are Robust Financials Driving The Recent Rally In Resonance Health Limited's (ASX:RHT) Stock?

If You Had Bought Resonance Health (ASX:RHT) Stock Three Years Ago, You Could Pocket A 855% Gain Today

Jan 15
If You Had Bought Resonance Health (ASX:RHT) Stock Three Years Ago, You Could Pocket A 855% Gain Today

How Does Resonance Health's (ASX:RHT) CEO Salary Compare to Peers?

Nov 22
How Does Resonance Health's (ASX:RHT) CEO Salary Compare to Peers?

Shareholder Returns

RHTAU Medical EquipmentAU Market
7D-1.9%-1.1%-1.2%
1Y-7.3%25.1%8.6%

Return vs Industry: RHT underperformed the Australian Medical Equipment industry which returned 25.1% over the past year.

Return vs Market: RHT underperformed the Australian Market which returned 8.6% over the past year.

Price Volatility

Is RHT's price volatile compared to industry and market?
RHT volatility
RHT Average Weekly Movement6.5%
Medical Equipment Industry Average Movement9.7%
Market Average Movement8.2%
10% most volatile stocks in AU Market16.3%
10% least volatile stocks in AU Market3.2%

Stable Share Price: RHT's share price has been volatile over the past 3 months.

Volatility Over Time: RHT's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1987n/aAndrew Harrisonwww.resonancehealth.com

Resonance Health Limited, a healthcare technology and services company, designs, develops, manufactures, and commercializes software-as-medical devices in the Asia Pacific, North America, Europe, the Middle East, and Africa. The company offers FerriScan, a non-invasive MRI based system for quantifying liver iron concentration (LIC); FerriSmart, an artificial intelligence (AI) assisted device for the automated real-time assessment of LIC; HepaFat-AI, an AI-trained device for the automated real-time multi-metric measurement of liver-fat; CardiacT2, a dual analysis service with FerriScan for assessing heart iron loading; HepaFat-Scan, a non-invasive MRI-based solution for the assessment of liver-fat in liver tissue; and LiverSmart, a non-invasive MRI-based multi-parametric device combining FerriSmart and HepaFat-AI into a consolidated report. It also provides quantitative imaging measurements and CRO services, such as quality-assured image analysis, project and data management, and issue resolution services; biomarkers, genomics, and laboratory analysis services, as well as works with third party pathology laboratories for blood/sample collection and for standard biochemical/lab safety assessments; design and protocol development, and project management and monitoring services; assessment of subject inclusion or exclusion, evaluating the safety profile of a new therapy, and supporting primary and secondary end-points demonstrating drug efficacy services; and phantoms for the MRI machines.

Resonance Health Limited Fundamentals Summary

How do Resonance Health's earnings and revenue compare to its market cap?
RHT fundamental statistics
Market capAU$24.58m
Earnings (TTM)-AU$1.09m
Revenue (TTM)AU$5.64m

4.0x

P/S Ratio

-21.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RHT income statement (TTM)
RevenueAU$5.64m
Cost of RevenueAU$0
Gross ProfitAU$5.64m
Other ExpensesAU$6.72m
Earnings-AU$1.09m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.0024
Gross Margin100.00%
Net Profit Margin-19.27%
Debt/Equity Ratio0%

How did RHT perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.